Can-Fite BioPharma Ltd.

Other News To Note.
BIOWORLD Today; 11/4/2009; 3528 words; ...entered a collaboration with Teijin Ltd., of Tokyo. Argenta will exploit...place. o Britannia Pharmaceuticals Ltd., of London, said study results...had a history of mild asthma. o Can-Fite BioPharma Ltd., of Petach Tikva, Israel, said...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1571 words; ...form of a nasal spray. o BioLineRx Ltd., of Jerusalem, said it has begun...meeting is planned for mid-June. o Can-Fite BioPharma, of Petach Tikva, Israel, has...analysis by ABR New Jersey, and Can-Fite plans to release a final report...

Can-Fite Initiates Preparatory Work for Psoriasis Phase III Trial with CF101.(Clinical report)
Business Wire; 9/30/2009; 1081 words; ...validates the technology platform of the company. CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange...Attorneys. Prof. Pnina Fishman serves as the CEO of Can-Fite. The Company was founded on the basis of scientific...

Can-Fite Announces Positive Results from its Psoriasis Phase II Trial with CF101.(Clinical report)
Business Wire; 9/8/2009; 1089 words; ...5 billion annually. The oral administration of Can-Fite's CF101, the drug's mechanism of action (suppression...support its use for the treatment of psoriasis. CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange...

Can-Fite BioPharma Expands its Pipeline by Licensing Allosteric Modulators from Leiden University and the NIH.
Business Wire; 7/28/2009; 1063 words; ...agent." In keeping with its financial reports, Can-Fite expects to release within weeks the results of a phase...successfully a Phase II study in Dry Eye Syndrome. CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange...